{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:47:04Z","timestamp":1784958424586,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009845","name":"Ovarian Cancer Research Foundation (OCRF)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009845","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Health and Medical Research Council of Australia"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.canep.2018.05.011","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T03:25:34Z","timestamp":1529551534000},"page":"110-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Risk of high-grade serous ovarian cancer associated with pelvic inflammatory disease, parity and breast cancer"],"prefix":"10.1016","volume":"55","author":[{"given":"Louise M.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Spilsbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. D\u2019Arcy J.","family":"Holman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aime","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Reekie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2018.05.011_bib0005","article-title":"Ovarian cancer: a heterogeneous disease","author":"Kossai","year":"2017","journal-title":"Pathobiology"},{"issue":"5","key":"10.1016\/j.canep.2018.05.011_bib0010","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/PAT.0b013e328348a6e7","article-title":"Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis","volume":"43","author":"McCluggage","year":"2011","journal-title":"Pathology"},{"issue":"3","key":"10.1016\/j.canep.2018.05.011_bib0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00428-012-1203-5","article-title":"Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features","volume":"460","author":"Prat","year":"2012","journal-title":"Virchows Arch."},{"key":"10.1016\/j.canep.2018.05.011_bib0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2016.08.006","article-title":"Epidemiology of epithelial ovarian cancer","volume":"41","author":"Webb","year":"2017","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.canep.2018.05.011_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GRF.0b013e31824b4611","article-title":"Ovarian cancer: etiology, risk factors, and epidemiology","volume":"55","author":"Hunn","year":"2012","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.canep.2018.05.011_bib0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/978-1-60327-492-0_20","article-title":"Epidemiology of ovarian cancer","volume":"472","author":"Permuth-Wey","year":"2009","journal-title":"Methods Mol. Biol."},{"issue":"9","key":"10.1016\/j.canep.2018.05.011_bib0035","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.0001-6349.2004.00550.x","article-title":"Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies","volume":"83","author":"Riman","year":"2004","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"4","key":"10.1016\/j.canep.2018.05.011_bib0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF00052668","article-title":"Reproductive factors and incidence of epithelial ovarian cancer: a Norwegian prospective study","volume":"7","author":"Albrektsen","year":"1996","journal-title":"Cancer Causes Control"},{"issue":"7","key":"10.1016\/j.canep.2018.05.011_bib0045","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.ejca.2007.01.035","article-title":"Risk factors for ovarian cancer histotypes","volume":"43","author":"Chiaffarino","year":"2007","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.canep.2018.05.011_bib0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/humupd\/dmq030","article-title":"Tubal ligation and the risk of ovarian cancer: review and meta-analysis","volume":"17","author":"Cibula","year":"2011","journal-title":"Hum. Reprod. Update"},{"issue":"5","key":"10.1016\/j.canep.2018.05.011_bib0055","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/ijc.29471","article-title":"Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: results from the EPIC cohort","volume":"137","author":"Fortner","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.canep.2018.05.011_bib0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ijc.31063","article-title":"Histological subtypes of ovarian cancer associated with parity and breastfeeding in the prospective million women study","volume":"142","author":"Gaitskell","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.canep.2018.05.011_bib0065","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ijc.29856","article-title":"Tubal ligation and ovarian cancer risk in a large cohort: substantial variation by histological type","volume":"138","author":"Gaitskell","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.canep.2018.05.011_bib0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/aje\/kwp314","article-title":"Risk factors for epithelial ovarian cancer by histologic subtype","volume":"171","author":"Gates","year":"2010","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.canep.2018.05.011_bib0075","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/aje\/kwn094","article-title":"Risk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish women","volume":"168","author":"Jensen","year":"2008","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.canep.2018.05.011_bib0080","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2004.10.037","article-title":"Histologic types of epithelial ovarian cancer: have they different risk factors?","volume":"96","author":"Kurian","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.canep.2018.05.011_bib0085","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ijc.2910420217","article-title":"Reproductive factors and risk of ovarian cancer: a prospective study","volume":"42","author":"Kvale","year":"1988","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.canep.2018.05.011_bib0090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/aogs.12516","article-title":"Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study","volume":"94","author":"Madsen","year":"2015","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"5","key":"10.1016\/j.canep.2018.05.011_bib0095","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/humrep\/des466","article-title":"Reproductive characteristics in relation to ovarian cancer risk by histologic pathways","volume":"28","author":"Merritt","year":"2013","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.canep.2018.05.011_bib0100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ijc.23017","article-title":"Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer","volume":"122","author":"Merritt","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.canep.2018.05.011_bib0105","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1047-2797(01)00213-7","article-title":"Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness","volume":"11","author":"Modugno","year":"2001","journal-title":"Ann. Epidemiol."},{"issue":"4","key":"10.1016\/j.canep.2018.05.011_bib0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1470-2045(11)70404-1","article-title":"Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies","volume":"13","author":"Pearce","year":"2012","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.canep.2018.05.011_bib0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1158\/1055-9965.EPI-16-0459","article-title":"Is Pelvic inflammatory disease a risk factor for ovarian cancer?","volume":"26","author":"Rasmussen","year":"2017","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"1","key":"10.1016\/j.canep.2018.05.011_bib0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1757-2215-5-13","article-title":"Tubal ligation, hysterectomy and ovarian cancer: a meta-analysis","volume":"5","author":"Rice","year":"2012","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.canep.2018.05.011_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.03.041","article-title":"Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the nurses\u2019 health studies","volume":"102","author":"Rice","year":"2014","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.canep.2018.05.011_bib0130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/oxfordjournals.aje.a008937","article-title":"Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study","volume":"144","author":"Risch","year":"1996","journal-title":"Am. J. Epidemiol."},{"issue":"11","key":"10.1016\/j.canep.2018.05.011_bib0135","first-page":"933","article-title":"Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization collaborative study of neoplasia and steroid contraceptives","volume":"5","author":"Rosenblatt","year":"1996","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"7","key":"10.1016\/j.canep.2018.05.011_bib0140","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/aje\/kwg177","article-title":"Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study","volume":"158","author":"Tung","year":"2003","journal-title":"Am. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.canep.2018.05.011_bib0145","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jnci\/58.4.913","article-title":"Marital status and incidence of ovarian cancer: the U.S. third national cancer survey, 1969--71","volume":"58","author":"Weiss","year":"1977","journal-title":"J. Natl. Cancer Inst."},{"issue":"24","key":"10.1016\/j.canep.2018.05.011_bib0150","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","article-title":"Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium","volume":"34","author":"Wentzensen","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.canep.2018.05.011_bib0155","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/ijc.26469","article-title":"Ovarian cancer risk factors by histologic subtypes in the NIH-AARP diet and health study","volume":"131","author":"Yang","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.canep.2018.05.011_bib0160","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.bjc.6603687","article-title":"Twin births, sex of children and maternal risk of ovarian cancer: a cohort study in Norway","volume":"96","author":"Albrektsen","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.canep.2018.05.011_bib0165","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1677\/ERC-07-0088","article-title":"Risks of breast, endometrial, and ovarian cancers after twin births","volume":"14","author":"Ji","year":"2007","journal-title":"Endocr. Relat. Cancer"},{"issue":"5","key":"10.1016\/j.canep.2018.05.011_bib0170","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/aje\/kwp185","article-title":"Beyond parity: association of ovarian cancer with length of gestation and offspring characteristics","volume":"170","author":"Jordan","year":"2009","journal-title":"Am. J. Epidemiol."},{"issue":"9168","key":"10.1016\/j.canep.2018.05.011_bib0175","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(99)02000-0","article-title":"Twinning and maternal risk of ovarian cancer","volume":"353","author":"Lambe","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.canep.2018.05.011_bib0180","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1375\/twin.8.2.156","article-title":"The effects of twins, parity and age at first birth on cancer risk in Swedish women","volume":"8","author":"Neale","year":"2005","journal-title":"Twin Res. Hum. Genet."},{"issue":"8","key":"10.1016\/j.canep.2018.05.011_bib0185","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1023\/B:CACO.0000043433.09264.58","article-title":"Twinning and the incidence of breast and gynecological cancers (United States)","volume":"15","author":"Neale","year":"2004","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1016\/j.canep.2018.05.011_bib0190","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1054\/bjoc.2000.1596","article-title":"Menstrual and reproductive factors in relation to ovarian cancer risk","volume":"84","author":"Titus-Ernstoff","year":"2001","journal-title":"Br. J. Cancer"},{"issue":"14","key":"10.1016\/j.canep.2018.05.011_bib0195","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jnci\/92.14.1172","article-title":"Multiple births and risk of epithelial ovarian cancer","volume":"92","author":"Whiteman","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"17","key":"10.1016\/j.canep.2018.05.011_bib0200","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","article-title":"Possible role of ovarian epithelial inflammation in ovarian cancer","volume":"91","author":"Ness","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.canep.2018.05.011_bib0205","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00001648-200003000-00006","article-title":"Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer","volume":"11","author":"Ness","year":"2000","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.canep.2018.05.011_bib0210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/aje\/kww161","article-title":"Pelvic inflammatory disease and the risk of ovarian cancer and borderline ovarian tumors: a pooled analysis of 13 case-control studies","volume":"185","author":"Rasmussen","year":"2017","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.canep.2018.05.011_bib0215","series-title":"Enabling Health and Medical Research in Western Australia","author":"Data Linkage Western Australia","year":"2018"},{"issue":"4","key":"10.1016\/j.canep.2018.05.011_bib0220","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1071\/AH080766","article-title":"A decade of data linkage in Western Australia: strategic design, applications and benefits of the WA data linkage system","volume":"32","author":"Holman","year":"2008","journal-title":"Aust. Health Rev."},{"key":"10.1016\/j.canep.2018.05.011_bib0225","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0067205X0403200307","article-title":"Compulsory voting in Australia: a basis for a best practice regime","volume":"32","author":"Hill","year":"2004","journal-title":"Fed. Law Rev."},{"issue":"4","key":"10.1016\/j.canep.2018.05.011_bib0230","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/PGP.0000000000000342","article-title":"Value of pathology review in a population-based series of ovarian tumors","volume":"36","author":"Stewart","year":"2017","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"15","key":"10.1016\/j.canep.2018.05.011_bib0235","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects","volume":"21","author":"Royston","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.canep.2018.05.011_bib0240","series-title":"Breast Cancer Epidemiology. New York","first-page":"1","article-title":"Global burden of breast cancer","author":"Ferlay","year":"2010"},{"issue":"7261","key":"10.1016\/j.canep.2018.05.011_bib0245","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bmj.321.7261.624","article-title":"ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics","volume":"321","author":"McPherson","year":"2000","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.canep.2018.05.011_bib0250","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jama.2017.21926","article-title":"Screening for ovarian cancer: US preventive services task force recommendation statement","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.canep.2018.05.011_bib0255","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jama.2017.21421","article-title":"Screening for ovarian cancer: updated evidence report and systematic review for the US preventive services task force","volume":"319","author":"Henderson","year":"2018","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.canep.2018.05.011_bib0260","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1158\/1055-9965.EPI-16-0011","article-title":"Parity and oral contraceptive use in relation to ovarian cancer risk in older women","volume":"25","author":"McGuire","year":"2016","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"1","key":"10.1016\/j.canep.2018.05.011_bib0265","first-page":"42","article-title":"Timing of pregnancy and the risk of epithelial ovarian cancer","volume":"12","author":"Whiteman","year":"2003","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"12","key":"10.1016\/j.canep.2018.05.011_bib0270","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/ijc.30910","article-title":"Timing of births and oral contraceptive use influences ovarian cancer risk","volume":"141","author":"Wu","year":"2017","journal-title":"Int. J. Cancer."},{"issue":"6","key":"10.1016\/j.canep.2018.05.011_bib0275","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju091","article-title":"Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis","volume":"106","author":"Friebel","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.canep.2018.05.011_bib0280","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/ijc.29386","article-title":"Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers","volume":"137","author":"Kotsopoulos","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.canep.2018.05.011_bib0285","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM200107263450401","article-title":"Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation","volume":"345","author":"Modan","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.canep.2018.05.011_bib0290","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ygyno.2012.10.023","article-title":"In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk","volume":"128","author":"Stewart","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.canep.2018.05.011_bib0295","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/ijc.30826","article-title":"Does an epidemiological comparison support a common cellular lineage for similar subtypes of postmenopausal uterine and ovarian carcinoma? The Norwegian women and cancer study","volume":"141","author":"Jareid","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.canep.2018.05.011_bib0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol. Med."},{"issue":"4","key":"10.1016\/j.canep.2018.05.011_bib0305","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1525-1438.2007.01089.x","article-title":"Inflammation: its role and interplay in the development of cancer, with special focus on gynecological malignancies","volume":"18","author":"Goswami","year":"2008","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782118302315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782118302315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T16:09:57Z","timestamp":1571501397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782118302315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":61,"alternative-id":["S1877782118302315"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2018.05.011","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of high-grade serous ovarian cancer associated with pelvic inflammatory disease, parity and breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2018.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}